| scholarly article | Q13442814 |
| P2093 | author name string | James W Welsh | |
| Ritsuko Komaki | |||
| Miho Kono | |||
| Pamela K Allen | |||
| James D Cox | |||
| Steven H Lin | |||
| Xiong Wei | |||
| Melenda D Jeter | |||
| P2860 | cites work | Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 |
| Origins, genetic landscape, and emerging therapies of small cell lung cancer | Q26798218 | ||
| Combining radiation and immunotherapy: a new systemic therapy for solid tumors? | Q26991721 | ||
| Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? | Q28072341 | ||
| Reduced lung-cancer mortality with low-dose computed tomographic screening | Q28241954 | ||
| Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. | Q31107011 | ||
| Small cell lung cancer: where do we go from here? | Q33872327 | ||
| Therapy-associated solid tumors | Q34861309 | ||
| RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer | Q34935948 | ||
| Small cell lung cancer: will recent progress lead to improved outcomes? | Q35836257 | ||
| Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma | Q36243414 | ||
| Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations | Q36359653 | ||
| Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with lim | Q36526895 | ||
| Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes? | Q36811784 | ||
| Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors | Q38093037 | ||
| Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer | Q38322114 | ||
| Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. | Q39282659 | ||
| Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells | Q39370246 | ||
| Oat cell carcinoma of the lung. A review of 138 cases | Q40066219 | ||
| Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease? | Q40633491 | ||
| High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors | Q42598884 | ||
| p53 mutations in human lung tumors | Q43755264 | ||
| Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre | Q43810416 | ||
| Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. | Q44064110 | ||
| Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. | Q50789972 | ||
| Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma. | Q50985747 | ||
| The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern | Q68258204 | ||
| Second lung cancers in patients after treatment for an initial lung cancer | Q77331946 | ||
| Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide | Q77912158 | ||
| Small-cell lung cancer | Q81354821 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1696-1703 | |
| P577 | publication date | 2017-08-10 | |
| P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
| P1476 | title | Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival | |
| P478 | volume | 12 |
Search more.